Traumatic and nontraumatic spinal-cord-injured patients in Quebec, Canada. Part 3: pharmacological characteristics
Study design: Community-based, cross-sectional study. Objectives: This study aimed at examining and comparing the pharmacological treatments administered to traumatic and nontraumatic spinal-cord-injured patients (TSCI, NTSCI). Setting: The Interval Rehabilitation Center, Trois-Rivieres, Province of...
Gespeichert in:
| Veröffentlicht in: | Spinal cord 2011-02, Vol.49 (2), p.186-195 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 195 |
|---|---|
| container_issue | 2 |
| container_start_page | 186 |
| container_title | Spinal cord |
| container_volume | 49 |
| creator | Rouleau, P Guertin, P A |
| description | Study design:
Community-based, cross-sectional study.
Objectives:
This study aimed at examining and comparing the pharmacological treatments administered to traumatic and nontraumatic spinal-cord-injured patients (TSCI, NTSCI).
Setting:
The Interval Rehabilitation Center, Trois-Rivieres, Province of Quebec, Canada.
Methods:
Medical records from a cohort of 175 chronic spinal-cord-injured patients (94 TSCI and 81 NTSCI individuals) were thoroughly studied.
Results:
More than 19 classes and more than 300 drugs were found to be administered to SCI patients. Among them, drugs against bowel and bladder problems, blood clot or deep venous thrombosis, cardiovascular problems, depression or anxiety, stomach acidity, infections, pain, inflammation, sleeping problems and vitamin deficiency were the most commonly used (between 35 and 66% of all SCI patients). Differences between groups were found specifically for antidepressants and anxiolytics used mainly by TSCI patients whereas bisphosphonates, bronchodilators, lipid regulators and anti-inflammatory drugs were used mainly by NTSCI patients.
Conclusion:
The results revealed an unexpectedly large number of drugs that are prescribed to both groups of SCI patients. Given the existence of between-group differences and known risks of drug–drug interactions, it is suggested that recommendations for each group should be made to carefully examine either the necessity or the effectiveness of each treatment as well as the possibility of developing alternative strategies based on physical activity, nutrition and lifestyle to eventually reduce, hopefully, the number of pharmacological treatments administered to these individuals. |
| doi_str_mv | 10.1038/sc.2010.70 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_954600422</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>954600422</sourcerecordid><originalsourceid>FETCH-LOGICAL-c470t-d07fdb6fec954c3dd1f1df0e84581fe68cfd4f3de49bc29a2ccd94957782ec453</originalsourceid><addsrcrecordid>eNqF0UuLFDEQB_AgivvQix9AgiALao95dXfiTQZ1FxZUWM9NTSVZM3Sn26T7sN_ejDPOwh70lEf9-CdUEfKCsxVnUr_PuBKsHFr2iJxy1TZV3Qj1uOxlIyoljTwhZzlvGWOGG_2UnAhWKy2FOCXpJsEywByQQrQ0jnE-XuQpROgrHJOtQtwuyVk6lYqLc6Yh0u-L2zh8R9cQwcKKfoM0U_mBTj8hDYBjP94GhJ5iOQPOLoVcYvMz8sRDn93zw3pOfnz-dLO-rK6_frlaf7yuULVsrixrvd003qGpFUpruefWM6dVrbl3jUZvlZfWKbNBYUAgWqNM3bZaOFS1PCcX-9wpjb8Wl-duCBld30N045K7EtswpoT4r9TKKMl5q4t89UBuxyWVLv1BQhnOVUFv9gjTmHNyvptSGCDddZx1u4l1GbvdxLqWFfzykLhsBmeP9O-ICnh9AJBLN32CiCHfO6llzVVT3Nu9y6UUb126_9q_no0wl8Ee4zLuRAG_Aa2It0s</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>849249114</pqid></control><display><type>article</type><title>Traumatic and nontraumatic spinal-cord-injured patients in Quebec, Canada. Part 3: pharmacological characteristics</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Rouleau, P ; Guertin, P A</creator><creatorcontrib>Rouleau, P ; Guertin, P A</creatorcontrib><description>Study design:
Community-based, cross-sectional study.
Objectives:
This study aimed at examining and comparing the pharmacological treatments administered to traumatic and nontraumatic spinal-cord-injured patients (TSCI, NTSCI).
Setting:
The Interval Rehabilitation Center, Trois-Rivieres, Province of Quebec, Canada.
Methods:
Medical records from a cohort of 175 chronic spinal-cord-injured patients (94 TSCI and 81 NTSCI individuals) were thoroughly studied.
Results:
More than 19 classes and more than 300 drugs were found to be administered to SCI patients. Among them, drugs against bowel and bladder problems, blood clot or deep venous thrombosis, cardiovascular problems, depression or anxiety, stomach acidity, infections, pain, inflammation, sleeping problems and vitamin deficiency were the most commonly used (between 35 and 66% of all SCI patients). Differences between groups were found specifically for antidepressants and anxiolytics used mainly by TSCI patients whereas bisphosphonates, bronchodilators, lipid regulators and anti-inflammatory drugs were used mainly by NTSCI patients.
Conclusion:
The results revealed an unexpectedly large number of drugs that are prescribed to both groups of SCI patients. Given the existence of between-group differences and known risks of drug–drug interactions, it is suggested that recommendations for each group should be made to carefully examine either the necessity or the effectiveness of each treatment as well as the possibility of developing alternative strategies based on physical activity, nutrition and lifestyle to eventually reduce, hopefully, the number of pharmacological treatments administered to these individuals.</description><identifier>ISSN: 1362-4393</identifier><identifier>EISSN: 1476-5624</identifier><identifier>DOI: 10.1038/sc.2010.70</identifier><identifier>PMID: 20548322</identifier><identifier>CODEN: SPCOFM</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>631/378/1687/1825 ; 631/92/436 ; Anatomy ; Biological and medical sciences ; Biomedical and Life Sciences ; Biomedicine ; Cerebrospinal fluid. Meninges. Spinal cord ; Comorbidity - trends ; Cross-Sectional Studies ; Drug Interactions - physiology ; Female ; Human Physiology ; Humans ; Injuries of the nervous system and the skull. Diseases due to physical agents ; Male ; Medical sciences ; Nervous system (semeiology, syndromes) ; Neurochemistry ; Neurology ; Neuropsychology ; Neurosciences ; original-article ; Polypharmacy ; Quebec - epidemiology ; Spinal Cord Diseases - diagnosis ; Spinal Cord Diseases - drug therapy ; Spinal Cord Diseases - epidemiology ; Spinal Cord Injuries - diagnosis ; Spinal Cord Injuries - drug therapy ; Spinal Cord Injuries - epidemiology ; Traumas. Diseases due to physical agents</subject><ispartof>Spinal cord, 2011-02, Vol.49 (2), p.186-195</ispartof><rights>International Spinal Cord Society 2011</rights><rights>2015 INIST-CNRS</rights><rights>Copyright Nature Publishing Group Feb 2011</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c470t-d07fdb6fec954c3dd1f1df0e84581fe68cfd4f3de49bc29a2ccd94957782ec453</citedby><cites>FETCH-LOGICAL-c470t-d07fdb6fec954c3dd1f1df0e84581fe68cfd4f3de49bc29a2ccd94957782ec453</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,782,786,27933,27934</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23835146$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20548322$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rouleau, P</creatorcontrib><creatorcontrib>Guertin, P A</creatorcontrib><title>Traumatic and nontraumatic spinal-cord-injured patients in Quebec, Canada. Part 3: pharmacological characteristics</title><title>Spinal cord</title><addtitle>Spinal Cord</addtitle><addtitle>Spinal Cord</addtitle><description>Study design:
Community-based, cross-sectional study.
Objectives:
This study aimed at examining and comparing the pharmacological treatments administered to traumatic and nontraumatic spinal-cord-injured patients (TSCI, NTSCI).
Setting:
The Interval Rehabilitation Center, Trois-Rivieres, Province of Quebec, Canada.
Methods:
Medical records from a cohort of 175 chronic spinal-cord-injured patients (94 TSCI and 81 NTSCI individuals) were thoroughly studied.
Results:
More than 19 classes and more than 300 drugs were found to be administered to SCI patients. Among them, drugs against bowel and bladder problems, blood clot or deep venous thrombosis, cardiovascular problems, depression or anxiety, stomach acidity, infections, pain, inflammation, sleeping problems and vitamin deficiency were the most commonly used (between 35 and 66% of all SCI patients). Differences between groups were found specifically for antidepressants and anxiolytics used mainly by TSCI patients whereas bisphosphonates, bronchodilators, lipid regulators and anti-inflammatory drugs were used mainly by NTSCI patients.
Conclusion:
The results revealed an unexpectedly large number of drugs that are prescribed to both groups of SCI patients. Given the existence of between-group differences and known risks of drug–drug interactions, it is suggested that recommendations for each group should be made to carefully examine either the necessity or the effectiveness of each treatment as well as the possibility of developing alternative strategies based on physical activity, nutrition and lifestyle to eventually reduce, hopefully, the number of pharmacological treatments administered to these individuals.</description><subject>631/378/1687/1825</subject><subject>631/92/436</subject><subject>Anatomy</subject><subject>Biological and medical sciences</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cerebrospinal fluid. Meninges. Spinal cord</subject><subject>Comorbidity - trends</subject><subject>Cross-Sectional Studies</subject><subject>Drug Interactions - physiology</subject><subject>Female</subject><subject>Human Physiology</subject><subject>Humans</subject><subject>Injuries of the nervous system and the skull. Diseases due to physical agents</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Nervous system (semeiology, syndromes)</subject><subject>Neurochemistry</subject><subject>Neurology</subject><subject>Neuropsychology</subject><subject>Neurosciences</subject><subject>original-article</subject><subject>Polypharmacy</subject><subject>Quebec - epidemiology</subject><subject>Spinal Cord Diseases - diagnosis</subject><subject>Spinal Cord Diseases - drug therapy</subject><subject>Spinal Cord Diseases - epidemiology</subject><subject>Spinal Cord Injuries - diagnosis</subject><subject>Spinal Cord Injuries - drug therapy</subject><subject>Spinal Cord Injuries - epidemiology</subject><subject>Traumas. Diseases due to physical agents</subject><issn>1362-4393</issn><issn>1476-5624</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqF0UuLFDEQB_AgivvQix9AgiALao95dXfiTQZ1FxZUWM9NTSVZM3Sn26T7sN_ejDPOwh70lEf9-CdUEfKCsxVnUr_PuBKsHFr2iJxy1TZV3Qj1uOxlIyoljTwhZzlvGWOGG_2UnAhWKy2FOCXpJsEywByQQrQ0jnE-XuQpROgrHJOtQtwuyVk6lYqLc6Yh0u-L2zh8R9cQwcKKfoM0U_mBTj8hDYBjP94GhJ5iOQPOLoVcYvMz8sRDn93zw3pOfnz-dLO-rK6_frlaf7yuULVsrixrvd003qGpFUpruefWM6dVrbl3jUZvlZfWKbNBYUAgWqNM3bZaOFS1PCcX-9wpjb8Wl-duCBld30N045K7EtswpoT4r9TKKMl5q4t89UBuxyWVLv1BQhnOVUFv9gjTmHNyvptSGCDddZx1u4l1GbvdxLqWFfzykLhsBmeP9O-ICnh9AJBLN32CiCHfO6llzVVT3Nu9y6UUb126_9q_no0wl8Ee4zLuRAG_Aa2It0s</recordid><startdate>20110201</startdate><enddate>20110201</enddate><creator>Rouleau, P</creator><creator>Guertin, P A</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T7</scope><scope>7TK</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20110201</creationdate><title>Traumatic and nontraumatic spinal-cord-injured patients in Quebec, Canada. Part 3: pharmacological characteristics</title><author>Rouleau, P ; Guertin, P A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c470t-d07fdb6fec954c3dd1f1df0e84581fe68cfd4f3de49bc29a2ccd94957782ec453</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>631/378/1687/1825</topic><topic>631/92/436</topic><topic>Anatomy</topic><topic>Biological and medical sciences</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cerebrospinal fluid. Meninges. Spinal cord</topic><topic>Comorbidity - trends</topic><topic>Cross-Sectional Studies</topic><topic>Drug Interactions - physiology</topic><topic>Female</topic><topic>Human Physiology</topic><topic>Humans</topic><topic>Injuries of the nervous system and the skull. Diseases due to physical agents</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Nervous system (semeiology, syndromes)</topic><topic>Neurochemistry</topic><topic>Neurology</topic><topic>Neuropsychology</topic><topic>Neurosciences</topic><topic>original-article</topic><topic>Polypharmacy</topic><topic>Quebec - epidemiology</topic><topic>Spinal Cord Diseases - diagnosis</topic><topic>Spinal Cord Diseases - drug therapy</topic><topic>Spinal Cord Diseases - epidemiology</topic><topic>Spinal Cord Injuries - diagnosis</topic><topic>Spinal Cord Injuries - drug therapy</topic><topic>Spinal Cord Injuries - epidemiology</topic><topic>Traumas. Diseases due to physical agents</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rouleau, P</creatorcontrib><creatorcontrib>Guertin, P A</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing & Allied Health Database</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Spinal cord</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rouleau, P</au><au>Guertin, P A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Traumatic and nontraumatic spinal-cord-injured patients in Quebec, Canada. Part 3: pharmacological characteristics</atitle><jtitle>Spinal cord</jtitle><stitle>Spinal Cord</stitle><addtitle>Spinal Cord</addtitle><date>2011-02-01</date><risdate>2011</risdate><volume>49</volume><issue>2</issue><spage>186</spage><epage>195</epage><pages>186-195</pages><issn>1362-4393</issn><eissn>1476-5624</eissn><coden>SPCOFM</coden><abstract>Study design:
Community-based, cross-sectional study.
Objectives:
This study aimed at examining and comparing the pharmacological treatments administered to traumatic and nontraumatic spinal-cord-injured patients (TSCI, NTSCI).
Setting:
The Interval Rehabilitation Center, Trois-Rivieres, Province of Quebec, Canada.
Methods:
Medical records from a cohort of 175 chronic spinal-cord-injured patients (94 TSCI and 81 NTSCI individuals) were thoroughly studied.
Results:
More than 19 classes and more than 300 drugs were found to be administered to SCI patients. Among them, drugs against bowel and bladder problems, blood clot or deep venous thrombosis, cardiovascular problems, depression or anxiety, stomach acidity, infections, pain, inflammation, sleeping problems and vitamin deficiency were the most commonly used (between 35 and 66% of all SCI patients). Differences between groups were found specifically for antidepressants and anxiolytics used mainly by TSCI patients whereas bisphosphonates, bronchodilators, lipid regulators and anti-inflammatory drugs were used mainly by NTSCI patients.
Conclusion:
The results revealed an unexpectedly large number of drugs that are prescribed to both groups of SCI patients. Given the existence of between-group differences and known risks of drug–drug interactions, it is suggested that recommendations for each group should be made to carefully examine either the necessity or the effectiveness of each treatment as well as the possibility of developing alternative strategies based on physical activity, nutrition and lifestyle to eventually reduce, hopefully, the number of pharmacological treatments administered to these individuals.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>20548322</pmid><doi>10.1038/sc.2010.70</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1362-4393 |
| ispartof | Spinal cord, 2011-02, Vol.49 (2), p.186-195 |
| issn | 1362-4393 1476-5624 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_954600422 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | 631/378/1687/1825 631/92/436 Anatomy Biological and medical sciences Biomedical and Life Sciences Biomedicine Cerebrospinal fluid. Meninges. Spinal cord Comorbidity - trends Cross-Sectional Studies Drug Interactions - physiology Female Human Physiology Humans Injuries of the nervous system and the skull. Diseases due to physical agents Male Medical sciences Nervous system (semeiology, syndromes) Neurochemistry Neurology Neuropsychology Neurosciences original-article Polypharmacy Quebec - epidemiology Spinal Cord Diseases - diagnosis Spinal Cord Diseases - drug therapy Spinal Cord Diseases - epidemiology Spinal Cord Injuries - diagnosis Spinal Cord Injuries - drug therapy Spinal Cord Injuries - epidemiology Traumas. Diseases due to physical agents |
| title | Traumatic and nontraumatic spinal-cord-injured patients in Quebec, Canada. Part 3: pharmacological characteristics |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-03T02%3A53%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Traumatic%20and%20nontraumatic%20spinal-cord-injured%20patients%20in%20Quebec,%20Canada.%20Part%203:%20pharmacological%20characteristics&rft.jtitle=Spinal%20cord&rft.au=Rouleau,%20P&rft.date=2011-02-01&rft.volume=49&rft.issue=2&rft.spage=186&rft.epage=195&rft.pages=186-195&rft.issn=1362-4393&rft.eissn=1476-5624&rft.coden=SPCOFM&rft_id=info:doi/10.1038/sc.2010.70&rft_dat=%3Cproquest_cross%3E954600422%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=849249114&rft_id=info:pmid/20548322&rfr_iscdi=true |